US Patent Issued to QURIENT on Oct. 6 for "Compounds for degradation of cyclin-dependent kinase 7(CDK7)" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,181, issued on Oct. 6, was assigned to QURIENT Co. LTD. (Gyeonggi-Do, South Korea).

"Compounds for degradation of cyclin-dependent kinase 7(CDK7)" was invented by Kiyean Nam (Gyeonggi-Do, South Korea), Jaeseung Kim (Seoul, South Korea), Dongsik Park (Gyeonggi-Do, South Korea), Mooyoung Seo (Gyeonggi-Do, South Korea), Yeejin Jeon (Gyeonggi-Do, South Korea) and Donghoon Yu (Gyeonggi-Do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds for degradation of cyclin-dependent kinase 7 (CDK7). The present invention also relates to pharmaceutical compositions comprising such compound(s). Furthermore, the pre...